Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 20Squamous Cell Carcinoma of Head and Neck 19Esophageal Neoplasms 19Head and Neck Neoplasms 13Nasopharyngeal Carcinoma 12Uterine Cervical Neoplasms 11Pancreatic Neoplasms 9Oropharyngeal Neoplasms 8Lung Neoplasms 7Glioblastoma 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Squamous Cell 6Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Mouth Neoplasms 4Hypopharyngeal Neoplasms 4Colorectal Neoplasms 4Carcinoma 4Adenocarcinoma 4Radiation Injuries 3Pathologic Complete Response 3Laryngeal Neoplasms 3Breast Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms by Site 2Nasopharyngeal Neoplasms 2NSCLC 2

Interventions

endostar protein 1coenzyme Q10 1apatinib 1Yoga 1Ubiquinone 1Tamoxifen 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Palliative Care 1Oxaliplatin 1Melatonin 1Gardening 1Fentanyl 1Exercise 1Educational Status 1Diet Therapy 1Chemoradiotherapy 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Quality of Life × Chemoradiotherapy × Clear all
NCT03588494 2018-07-17

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Affiliated Hospital of North Sichuan Medical College

Phase 2/3 Unknown
318 enrolled

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡